ici 204,219 has been researched along with Recrudescence in 3 studies
zafirlukast: a leukotriene D4 receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, D | 1 |
| Saltoun, CA | 1 |
| White, DJ | 1 |
| Vanthuyne, A | 1 |
| Wood, PM | 1 |
| Ayres, JG | 1 |
| Silverman, RA | 1 |
| Nowak, RM | 1 |
| Korenblat, PE | 1 |
| Skobeloff, E | 1 |
| Chen, Y | 1 |
| Bonuccelli, CM | 1 |
| Miller, CJ | 1 |
| Simonson, SG | 1 |
1 trial available for ici 204,219 and Recrudescence
| Article | Year |
|---|---|
Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Child; Double-Blind Method; E | 2004 |
2 other studies available for ici 204,219 and Recrudescence
| Article | Year |
|---|---|
Facial swelling and eosinophilia in a 44-year-old woman.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Angioedema; Cefuroxime; Cetirizine; Diagnosis, Diffe | 2002 |
Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.
Topics: Adult; Candidiasis, Vulvovaginal; Female; Follow-Up Studies; Humans; Hypersensitivity; Indoles; Leuk | 2004 |